Premium
The Critical Path Institute's Approach to Precompetitive Sharing and Advancing Regulatory Science
Author(s) -
Woosley R L,
Myers R T,
Goodsaid F
Publication year - 2010
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2010.27
Subject(s) - path (computing) , regulatory science , medicine , computer science , pathology , programming language
Many successful large industries, such as computer‐chip manufacturers, the cable television industry, and high‐definition television developers, 1 have established successful precompetitive collaborations focusing on standards, applied science, and technology that advance the field for all stakeholders and benefit the public. 2 The pharmaceutical industry, however, has a well‐earned reputation for fierce competition and did not demonstrate willingness to share data or knowledge until the US Food and Drug Administration (FDA) launched the Critical Path Initiative in 2004 (ref. 3 ). Clinical Pharmacology & Therapeutics (2010) 87 5, 530–533. doi: 10.1038/clpt.2010.27